A Northern California court ordered Commure to stop selling its wearable panic buttons to hospitals after a legal battle with ...

Dayforce's shares no longer look appealing as valuation multiples against peers have compressed. Learn why DAY stock is a ...

Discover how B-Alive transformed from a single store to a thriving three-store chain, plus a digital storefront, with ECRS’ ...

By staying ahead of emerging trends, you can build stronger relationships, increase conversions and achieve sustainable ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Texas lawmakers are pushing bills to ban pet store sales of puppies and kittens, aiming to cut off supply chains tied to ...

FMC is in poor financial health. We calculate a net debt/adjusted EBITDA ratio of 4.3 times as of March 31. We expect FMC's leverage ratios will remain elevated over the next several years. However, ...

The Ethical Pet Sales Bill (HB 3458), aimed at curbing the sale of animals from large-scale commercial breeders, passed out ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

Mortgage adviser business pipelines are getting bigger, but their bank accounts aren't reflecting this growth.

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...